Open AccessMaternal and perinatal outcomes of hyperthyroidsm in pregnancy at Dr. Cipto Mangunkusumo Hospital, Jakarta, period of January 2015 - December 2016
Author(s) -
Fita Maulina,
Mohammad Adya Firmansha Dilmy,
Ali Sungkar
Publication year - 2021
Publication title -
majalah obstetri and ginekologi/majalah obstetri dan ginekologi
Language(s) - English
Resource type - Journals
eISSN - 2598-1013
pISSN - 0854-0381
DOI - 10.20473/mog.v29i12021.36-40
Subject(s) - medicine , pregnancy , obstetrics , complication , incidence (geometry) , abortion , preeclampsia , intrauterine growth restriction , fetus , perinatal mortality , pediatrics , gynecology , surgery , genetics , physics , optics , biology
Objectives: To report maternal and perinatal outcomes of hyperthyroidsm in pregnancy.Case Report: There were 3622 cases of delivering pregnant women during the period of the study. From this number, the prevalence of pregnant women with hyperthyroid was 0.2 %. We reported 9 cases of hyperthyroid in pregnancy. The number of pregnancy complication and outcome on pregnant women with hyperthyroidism were preterm labor (44%) and preeclampsia (22%), both were found in group of mother who did taking antihyperthyroid therapy. In those who did not take antihyperthyroid therapy 11% had spontaneous abortion and 11% had preterm delivery. Fetal complications were intrauterine growth restriction (11%) and intrauterine fetal death (23%), both of these complication were on the group who did not take antihyperthyroid. On the contrary, 44% babies were born with normal birthweight in group who took antihyperthyroid.Conclusion: There were differences noted between the group that took adequate treatment and the group that did not take antihyperthyroid. The incidence of intrauterine growth restriction and intrauterine fetal death were high in group that did not took antihyperthyroid therapy but the incidence of preterm delivery as the maternal complication was high in group that did take the antihyperthyroid therapy.